stocksDLCL
DLCL

Dr Lalchandani Labs Ltd.

6.96-0.2 (-2.66%)
23 Oct, 12:00 AM

Annual Reports and Financial Documents

Dr Lalchandani Labs Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
201820192020202120222023202420252026
Annual ReportsFY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025—
Quarterly Results—
Conference Calls—————————
Presentations—————————

Corporate Announcements and Regulatory Filings

Dr Lalchandani Labs Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201813 Oct 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    certificate under Regulation 74(5) for Quarter ended September 2026
  2. Closure of Trading Window30 Sept 2026
    Closure of Trading Window
    Trading Window Closure
  3. General17 Sept 2026
    Extension For Annual General Meeting For FY 2025-2026
    The company due to ill health of the Chairman of the Company had filed the Application for extension of Annual General Meeting (AGM) for FY 2025-26, the ROC Delhi has considered and approved ....
  4. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201817 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations for quarter ended June 2026
  5. Outcome of Board Meeting3 Jun 2026
    Board Meeting Outcome for Approval Of Audited Financial Statement For Half Year And Year Ended March 31, 2026
    Audited Financial Results for the quarter and year ended March 31, 2026
  6. Meeting Updates30 May 2026
    Announcement under Regulation 30 (LODR)-Meeting Updates
    Intimation of Postponement and Rescheduling of Board Meeting scheduled to be held on Today May 30, 2026.
  7. General28 May 2026
    Opening Of New Centre At Dwarka Delhi
    We are pleased to inform that the Company has successfully opened a new strategic Centre at Dwarka New Delhi.
  8. Board Meeting27 May 2026
    Board Meeting Intimation for Consideration And Approval Of Financial Results Of The Company For Half Year And Year Ended March 31, 2026
    Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve financial results of the ....
  9. Format of the Annual Disclosure to be made by an entity identified as a LC : Annexure B24 May 2026
    Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
    <b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....
  10. Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A30 Apr 2026
    Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
    <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
  11. Resignation of Company Secretary / Compliance Officer22 Apr 2026
    Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
    Resignation of Mrs. Saniya Hussain from the position of Company Secretary and Compliance Officer
  12. General13 Apr 2026
    Reply To The Clarification Sought By BSE
    Reply to the clarification sought by exchange dated April 13, 2026
  13. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20189 Apr 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under Regulation 74(5) of SEBI DP Regulations for Quarter ended March 2026
  14. Closure of Trading Window27 Mar 2026
    Closure of Trading Window
    Trading Window Closure for March 31, 2026
  15. Newspaper Publication6 Mar 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    post issue newspaper advertisements under Regulation 92
  16. Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 20115 Mar 2026
    Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Anuraag Gambhir
  17. General2 Mar 2026
    Approval Of Basis Of Allotment Under Right Issue
    Approval of basis of allotment under Right issue
  18. Outcome without intimation2 Mar 2026
    Board Meeting Outcome for Outcome Of Board Meeting Held On Monday March 02, 2026
    Board meeting for approval of basis of allotment for right issue
  19. Newspaper Publication17 Feb 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper publication for extension of issue closing date and extension of date of on market renunciation of Rights Entitlements.
  20. General16 Feb 2026
    Board Meeting Revised Outcome For Extension Of Issue Period
    We wish to inform you that the Board of Directors of the Company considered and approved the extension of closing date of the ongoing right issue. The issue has been extended to February ....

Frequently Asked Questions

Where can I download the annual report of Dr Lalchandani Labs Ltd.?
Annual reports of Dr Lalchandani Labs Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Dr Lalchandani Labs Ltd.?
Quarterly earnings results and presentations of Dr Lalchandani Labs Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Dr Lalchandani Labs Ltd. publish earnings call transcripts?
Earnings call transcripts of Dr Lalchandani Labs Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Dr Lalchandani Labs Ltd.?
Investor presentations and annual day presentations of Dr Lalchandani Labs Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Dr Lalchandani Labs Ltd.?
Corporate announcements and regulatory filings of Dr Lalchandani Labs Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Dr Lalchandani Labs Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Dr Lalchandani Labs Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Dr Lalchandani Labs Ltd.?
The ISIN (International Securities Identification Number) of Dr Lalchandani Labs Ltd. is INE871Z01013. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Dr Lalchandani Labs Ltd. listed?
Dr Lalchandani Labs Ltd. is listed on NSE and BSE. The NSE symbol is DLCL and the BSE code is -.
Where can I find the shareholding pattern of Dr Lalchandani Labs Ltd.?
The quarterly shareholding pattern of Dr Lalchandani Labs Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Dr Lalchandani Labs Ltd. on Sharpely?
Share price data for Dr Lalchandani Labs Ltd. is updated as of 23 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.